Page 3 - Forefront Analytics News Today

Forefront Analytics LLC grew its holdings in shares of Athira Pharma, Inc. (NASDAQ:ATHA – Free Report) by 43.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 29,765 shares of the company’s stock after purchasing an additional 8,955 shares during the […]

Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) was the recipient of a large drop in short interest in May. As of May 15th, there was short interest totalling 923,300 shares, a drop of 12.1% from the April 30th total of 1,050,000 shares. Currently, 2.6% of the company’s shares are sold short. Based on an […]

Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) was the target of a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 923,300 shares, a drop of 12.1% from the April 30th total of 1,050,000 shares. Based on an average daily trading volume, of 309,500 […]

Annexon, Inc. (NASDAQ:ANNX – Get Free Report) was the target of a large growth in short interest in May. As of May 15th, there was short interest totalling 7,570,000 shares, a growth of 25.3% from the April 30th total of 6,040,000 shares. Based on an average trading volume of 1,890,000 shares, the days-to-cover ratio is […]

Jasper Therapeutics, Inc. (NASDAQ:JSPR – Get Free Report) has been assigned an average recommendation of “Buy” from the nine research firms that are currently covering the stock, MarketBeat.com reports. Nine investment analysts have rated the stock with a buy recommendation. The average 12-month target price among analysts that have covered the stock in the last […]

Cantor Fitzgerald Investment Advisors L.P. purchased a new stake in shares of iShares Floating Rate Bond ETF (BATS:FLOT – Free Report) in the fourth quarter, HoldingsChannel.com reports. The institutional investor purchased 7,438 shares of the company’s stock, valued at approximately $377,000. A number of other hedge funds and other institutional investors also recently added to […]

Zura Bio Limited (NASDAQ:ZURA – Get Free Report) Director Van Amstel Arnout Ploos acquired 80,000 shares of the firm’s stock in a transaction that occurred on Friday, May 17th. The shares were bought at an average price of $6.20 per share, with a total value of $496,000.00. Following the acquisition, the director now directly owns […]

Annexon, Inc. (NASDAQ:ANNX – Get Free Report) has been given an average rating of “Buy” by the six analysts that are covering the company, MarketBeat.com reports. Six investment analysts have rated the stock with a buy rating. The average 1 year target price among analysts that have issued a report on the stock in the […]

Shares of Annexon, Inc. (NASDAQ:ANNX – Get Free Report) have been given a consensus rating of “Buy” by the six brokerages that are presently covering the firm, MarketBeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12-month price objective among analysts that have updated their coverage on the […]

JMP Securities reaffirmed their market outperform rating on shares of Athira Pharma (NASDAQ:ATHA – Free Report) in a research note released on Thursday morning, Benzinga reports. JMP Securities currently has a $19.00 price objective on the stock. Athira Pharma Price Performance Shares of ATHA stock opened at $2.52 on Thursday. Athira Pharma has a 1 […]